Linked Data API

Show Search Form

Search Results

1171131
registered interest false more like this
date less than 2020-01-15more like thismore than 2020-01-15
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Cannabis: Medical Treatments more like this
house id 1 remove filter
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, how many prescriptions for medical cannabis were issued by the NHS in 2019. more like this
tabling member constituency Inverclyde more like this
tabling member printed
Ronnie Cowan more like this
uin 3830 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2020-01-23more like thismore than 2020-01-23
answer text <p>NHS England and NHS Improvement is using extant systems to monitor the use of unlicensed cannabis-based products for medicinal use in England. In England, these systems monitor the number of items dispensed and associated costs in primary care and the volume of products used and associated cost in secondary care. NHS England and NHS Improvement Controlled Drug Accountable Officers are also collecting local intelligence in both the National Health Service and independent sector.</p><p>The NHS Business Services Authority is only able to provide information on prescriptions for cannabis-based medicines that have been prescribed and submitted to it. The NHS Business Services Authority does not hold information on prescriptions for cannabis-based medicines which have been issued but not fulfilled.</p><p>The following table shows the number of items for Nabilone, Sativex and Epidyolex (licensed cannabis-based medicines) and unlicensed cannabis-based medicines that were prescribed on an NHS prescription, dispensed in the community and submitted to the NHS Business Services Authority for reimbursement between January and October 2019 (October 2019 is the most recent dispensing data held by the NHS Business Services Authority).</p><p> </p><p> </p><table><tbody><tr><td rowspan="2"><p>Month</p></td><td colspan="3"><p>Licensed Cannabis-based medicines</p></td><td rowspan="2"><p>Unlicensed cannabis-based medicines</p></td></tr><tr><td><p>Nabilone</p></td><td><p>Sativex</p></td><td><p>Epidyolex *</p></td></tr><tr><td><p>January 2019</p></td><td><p>44</p></td><td><p>167</p></td><td><p> </p></td><td><p>2</p></td></tr><tr><td><p>February 2019</p></td><td><p>36</p></td><td><p>159</p></td><td><p> </p></td><td><p>1</p></td></tr><tr><td><p>March 2019</p></td><td><p>51</p></td><td><p>171</p></td><td><p> </p></td><td><p>2</p></td></tr><tr><td><p>April 2019</p></td><td><p>49</p></td><td><p>156</p></td><td><p> </p></td><td><p>2</p></td></tr><tr><td><p>May 2019</p></td><td><p>59</p></td><td><p>176</p></td><td><p> </p></td><td><p>2</p></td></tr><tr><td><p>June 2019</p></td><td><p>47</p></td><td><p>187</p></td><td><p> </p></td><td><p>2</p></td></tr><tr><td><p>July 2019</p></td><td><p>54</p></td><td><p>158</p></td><td><p> </p></td><td><p>2</p></td></tr><tr><td><p>August 2019</p></td><td><p>46</p></td><td><p>174</p></td><td><p> </p></td><td><p>1</p></td></tr><tr><td><p>September 2019</p></td><td><p>58</p></td><td><p>179</p></td><td><p>0</p></td><td><p>1</p></td></tr><tr><td><p>October 2019</p></td><td><p>46</p></td><td><p>173</p></td><td><p>0</p></td><td><p>1</p></td></tr><tr><td><p>Total</p></td><td><p>490</p></td><td><p>1,700</p></td><td><p>0</p></td><td><p>16</p></td></tr><tr><td><p>Grand Total</p></td><td colspan="4"><p>2,206</p></td></tr></tbody></table><p> </p><p>Note:</p><p>*Epidyolex was unlicensed prior to September 2019; no NHS prescriptions for Epidyolex have been submitted at the time this data was produced. In addition to the above, approximately 185 patients have accessed Epidyolex through the manufacturer’s (GW Pharma) early access programmes, ahead of a licensing decision by the European Medicines Agency.</p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p>
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill more like this
question first answered
less than 2020-01-23T12:23:43.063Zmore like thismore than 2020-01-23T12:23:43.063Z
answering member
4380
label Biography information for Jo Churchill more like this
tabling member
4465
label Biography information for Ronnie Cowan remove filter
1150683
registered interest false more like this
date less than 2019-10-18more like thismore than 2019-10-18
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Cannabis: Medical Treatments more like this
house id 1 remove filter
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, how many prescriptions for medical cannabis have been issued on the NHS since the rescheduling of cannabis-based products. more like this
tabling member constituency Inverclyde more like this
tabling member printed
Ronnie Cowan more like this
uin 1918 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-10-23more like thismore than 2019-10-23
answer text <p>Cannabis-based products for medicinal use were rescheduled on 1 November 2018 to allow clinicians on the General Medical Council’s ‘Specialist Register’ to prescribe cannabis-based products for medicinal use, where clinically appropriate and in the best interest of patients.</p><p>NHS England and NHS Improvement is using extant systems to monitor use of the newly rescheduled unlicensed cannabis-based products for medicinal use in England. In England, these systems monitor the number of items dispensed and associated costs in primary care and the volume of products used and associated cost in secondary care. NHS England’s and NHS Improvement’s Controlled Drug Accountable Officers are also collecting local intelligence in both the National Health Service and independent sector.</p><p> </p> more like this
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill more like this
question first answered
less than 2019-10-23T16:56:26.207Zmore like thismore than 2019-10-23T16:56:26.207Z
answering member
4380
label Biography information for Jo Churchill more like this
tabling member
4465
label Biography information for Ronnie Cowan remove filter
1150684
registered interest false more like this
date less than 2019-10-18more like thismore than 2019-10-18
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Cannabis: Medical Treatments more like this
house id 1 remove filter
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, how many prescriptions for medical cannabis were issued on the NHS from November 2017 to November 2018. more like this
tabling member constituency Inverclyde more like this
tabling member printed
Ronnie Cowan more like this
uin 1919 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-10-23more like thismore than 2019-10-23
answer text <p>NHS England and Improvement is using extant systems to monitor use of the newly rescheduled unlicensed cannabis-based products for medicinal use in England. In England, these systems monitor the number of items dispensed and associated costs in primary care and the volume of products used and associated cost in secondary care. NHS England’s and NHS Improvement’s Controlled Drug Accountable Officers are also collecting local intelligence in both the NHS and independent sector.</p><p>The NHS Business Services Authority is only able to provide information on prescriptions for cannabis-based medicines that have been prescribed and submitted to the NHS Business Services Authority. It does not hold information on prescriptions for cannabis-based medicines which have been issued but not fulfilled.</p><p>The following table shows the number of items for Nabilone and Sativex (licensed cannabis-based medicines) and unlicensed cannabis-based medicines that were prescribed on an National Health Service prescription, dispensed in the community and submitted to the NHS Business Services Authority for reimbursement between November 2017 and November 2018.</p><table><tbody><tr><td rowspan="2"><p>Month</p></td><td colspan="2"><p>Licensed cannabis-based medicines</p></td><td rowspan="2"><p>Unlicensed cannabis-based medicines</p></td></tr><tr><td><p>Nabilone</p></td><td><p>Sativex</p></td></tr><tr><td><p>November 2017</p></td><td><p>44</p></td><td><p>174</p></td><td><p>0</p></td></tr><tr><td><p>December 2017</p></td><td><p>58</p></td><td><p>202</p></td><td><p>0</p></td></tr><tr><td><p>January 2018</p></td><td><p>54</p></td><td><p>171</p></td><td><p>0</p></td></tr><tr><td><p>February 2018</p></td><td><p>44</p></td><td><p>158</p></td><td><p>0</p></td></tr><tr><td><p>March 2018</p></td><td><p>47</p></td><td><p>182</p></td><td><p>0</p></td></tr><tr><td><p>April 2018</p></td><td><p>48</p></td><td><p>145</p></td><td><p>0</p></td></tr><tr><td><p>May 2018</p></td><td><p>45</p></td><td><p>183</p></td><td><p>0</p></td></tr><tr><td><p>June 2018</p></td><td><p>42</p></td><td><p>157</p></td><td><p>0</p></td></tr><tr><td><p>July 2018</p></td><td><p>48</p></td><td><p>170</p></td><td><p>2</p></td></tr><tr><td><p>August 2018</p></td><td><p>54</p></td><td><p>161</p></td><td><p>0</p></td></tr><tr><td><p>September 2018</p></td><td><p>45</p></td><td><p>172</p></td><td><p>1</p></td></tr><tr><td><p>October 2018</p></td><td><p>50</p></td><td><p>164</p></td><td><p>0</p></td></tr><tr><td><p>November 2018</p></td><td><p>46</p></td><td><p>175</p></td><td><p>2</p></td></tr><tr><td><p>Total</p></td><td><p>625</p></td><td><p>2,214</p></td><td><p>5</p></td></tr></tbody></table><p> </p><p>Unlike NHS primary care where all dispensed prescriptions are processed centrally for payment, this is not the case for secondary care. This information is collected by a third party and not routinely published.</p>
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill more like this
question first answered
less than 2019-10-23T17:00:08.437Zmore like thismore than 2019-10-23T17:00:08.437Z
answering member
4380
label Biography information for Jo Churchill more like this
tabling member
4465
label Biography information for Ronnie Cowan remove filter
1142826
registered interest false more like this
date less than 2019-09-02more like thismore than 2019-09-02
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Cannabis: Medical Treatments more like this
house id 1 remove filter
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, how many prescriptions for medical cannabis have been issued on the NHS since the rescheduling of cannabis based products. more like this
tabling member constituency Inverclyde more like this
tabling member printed
Ronnie Cowan more like this
uin 284234 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-09-09more like thismore than 2019-09-09
answer text <p>NHS England and NHS Improvement are using extant systems to monitor use of the newly rescheduled unlicensed cannabis-based products for medicinal use in England. In England, these systems monitor the number of items dispensed and associated costs in primary care and the volume of products used and associated cost in secondary care. NHS England and NHS Improvement Controlled Drug Accountable Officers are also collecting local intelligence in both the National Health Service and independent sector.</p><p>The NHS Business Services Authority (NHSBSA) is only able to provide information on prescriptions for cannabis-based medicines that have been prescribed and submitted to the NHS Business Services Authority. It does not hold information on prescriptions for cannabis-based medicines which have been issued but not fulfilled.</p><p>The following table shows the number of items for Nabilone and Sativex (licensed cannabis-based medicines) and unlicensed cannabis-based medicines that were prescribed on a NHS prescription, dispensed in the community and submitted to the NHS Business Services Authority for reimbursement between November 2018 and June 2019.</p><table><tbody><tr><td rowspan="2"><p>Month</p></td><td colspan="2"><p>Licensed cannabis-based medicines</p></td><td rowspan="2"><p>Unlicensed cannabis-based medicines</p></td></tr><tr><td><p>Nabilone</p></td><td><p>Sativex</p></td></tr><tr><td><p>November 2018</p></td><td><p>46</p></td><td><p>175</p></td><td><p>2</p></td></tr><tr><td><p>December 2018</p></td><td><p>49</p></td><td><p>181</p></td><td><p>1</p></td></tr><tr><td><p>January 2019</p></td><td><p>44</p></td><td><p>167</p></td><td><p>2</p></td></tr><tr><td><p>February 2019</p></td><td><p>36</p></td><td><p>159</p></td><td><p>1</p></td></tr><tr><td><p>March 2019</p></td><td><p>51</p></td><td><p>171</p></td><td><p>2</p></td></tr><tr><td><p>April 2019</p></td><td><p>49</p></td><td><p>156</p></td><td><p>2</p></td></tr><tr><td><p>May 2019</p></td><td><p>59</p></td><td><p>176</p></td><td><p>2</p></td></tr><tr><td><p>June 2019</p></td><td><p>47</p></td><td><p>187</p></td><td><p>0</p></td></tr><tr><td><p>Total</p></td><td><p>381</p></td><td><p>1,372</p></td><td><p>12</p></td></tr></tbody></table><p><strong> </strong></p><p>In addition to the above, 185 patients have accessed Epidiolex/Epidyolex though the manufacturer’s (GW Pharma) early access programmes ahead of a licensing decision by the European Medicines Agency.</p>
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill more like this
question first answered
less than 2019-09-09T15:20:43.287Zmore like thismore than 2019-09-09T15:20:43.287Z
answering member
4380
label Biography information for Jo Churchill more like this
tabling member
4465
label Biography information for Ronnie Cowan remove filter
1143439
registered interest false more like this
date less than 2019-09-02more like thismore than 2019-09-02
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Cannabis: Medical Treatments more like this
house id 1 remove filter
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, if his Department will produce a cross-government plan for the issuing of medicinal cannabis under prescription by the end of 2019. more like this
tabling member constituency Inverclyde more like this
tabling member printed
Ronnie Cowan more like this
uin 284922 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-09-09more like thismore than 2019-09-09
answer text <p>The Department will continue to work closely with other Departments to implement the Government’s policy on access to cannabis-based products for medicinal use; to work with researchers, the industry and others to improve the evidence base for these products; to ensure product availability; and to provide clinicians with guidance on prescribing these products where clinically appropriate.</p> more like this
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill more like this
question first answered
less than 2019-09-09T15:22:26.847Zmore like thismore than 2019-09-09T15:22:26.847Z
answering member
4380
label Biography information for Jo Churchill more like this
tabling member
4465
label Biography information for Ronnie Cowan remove filter
1088418
registered interest false more like this
date less than 2019-03-13more like thismore than 2019-03-13
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Cannabis: Medical Treatments more like this
house id 1 remove filter
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 18 January 2019 to Question 207185 on Cannabis: Medical Treatments, whether data on prescriptions of cannabis-based medicinal products will (a) be published in the public domain, (b) include UK-wide data and (c) include the numbers of people obtaining a such a prescription. more like this
tabling member constituency Inverclyde more like this
tabling member printed
Ronnie Cowan more like this
uin 232047 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-03-21more like thismore than 2019-03-21
answer text <p>NHS England is using extant systems to monitor use of the newly rescheduled unlicensed cannabis-based products for medicinal use in England. Scotland, Wales and Northern Ireland are in the process of setting up similar systems.</p><p> </p><p>In England, these systems monitor the number of items dispensed and associated costs in primary care and the volume of products used and associated cost in secondary care. NHS England Controlled Drug Accountable Officers are also collecting local intelligence in both the National Health Service and independent sector. We expect this data to be available by end of March 2019.</p> more like this
answering member constituency Winchester more like this
answering member printed Steve Brine more like this
grouped question UIN 232048 more like this
question first answered
less than 2019-03-21T16:18:12.947Zmore like thismore than 2019-03-21T16:18:12.947Z
answering member
4067
label Biography information for Steve Brine more like this
tabling member
4465
label Biography information for Ronnie Cowan remove filter
1088420
registered interest false more like this
date less than 2019-03-13more like thismore than 2019-03-13
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Cannabis: Medical Treatments more like this
house id 1 remove filter
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 18 January 2019 to Question 207185 on Cannabis: Medical Treatments, whether data on prescriptions of cannabis-based medicinal products will include (a) the type of product prescribed, (b) the indication that product was prescribed for and (c) the number of those such prescriptions by NHS clinical commissioning group area. more like this
tabling member constituency Inverclyde more like this
tabling member printed
Ronnie Cowan more like this
uin 232048 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-03-21more like thismore than 2019-03-21
answer text <p>NHS England is using extant systems to monitor use of the newly rescheduled unlicensed cannabis-based products for medicinal use in England. Scotland, Wales and Northern Ireland are in the process of setting up similar systems.</p><p> </p><p>In England, these systems monitor the number of items dispensed and associated costs in primary care and the volume of products used and associated cost in secondary care. NHS England Controlled Drug Accountable Officers are also collecting local intelligence in both the National Health Service and independent sector. We expect this data to be available by end of March 2019.</p> more like this
answering member constituency Winchester more like this
answering member printed Steve Brine more like this
grouped question UIN 232047 more like this
question first answered
less than 2019-03-21T16:18:12.993Zmore like thismore than 2019-03-21T16:18:12.993Z
answering member
4067
label Biography information for Steve Brine more like this
tabling member
4465
label Biography information for Ronnie Cowan remove filter
1029395
registered interest false more like this
date less than 2018-12-20more like thismore than 2018-12-20
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Drugs: Death more like this
house id 1 remove filter
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, whether his Department has held discussions with representatives of (a) drug support charities and (b) other organisations on the level of drug-related deaths in relation to the abstinence and recovery agenda set out the Drug Strategy. more like this
tabling member constituency Inverclyde more like this
tabling member printed
Ronnie Cowan more like this
uin 204555 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-01-14more like thismore than 2019-01-14
answer text <p>Public Health England regularly holds discussions with representatives of drug charities and other organisations on drug-related deaths. This includes convening a national intelligence network on the health harms associated with drug use. Member organisations include providers of drug treatment services, and national professional and membership bodies. The network exchanges intelligence on drug-related deaths, and explores how to use this intelligence to inform commissioning and practice.</p> more like this
answering member constituency Winchester more like this
answering member printed Steve Brine more like this
question first answered
less than 2019-01-14T16:18:17.663Zmore like thismore than 2019-01-14T16:18:17.663Z
answering member
4067
label Biography information for Steve Brine more like this
tabling member
4465
label Biography information for Ronnie Cowan remove filter